Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Suboptimal use of statins at treatment initiation.

× No keyword cloud information.

13 in total

1. Impact of restricted reimbursement on the use of statins in Finland: a register-based study.

Authors: Jaana E Martikainen; Leena K Saastamoinen; Maarit J Korhonen; Hannes Enlund; Arja Helin-Salmivaara
Journal: Med Care Date: 2010-09 Impact factor: 2.983

2. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.

Authors: Gunnar H Gislason; Jeppe N Rasmussen; Steen Z Abildstrøm; Niels Gadsbøll; Pernille Buch; Jens Friberg; Søren Rasmussen; Lars Køber; Steen Stender; Mette Madsen; Christian Torp-Pedersen
Journal: Eur Heart J Date: 2006-01-06 Impact factor: 29.983

3. Suboptimal choices and dosing of statins at start of therapy.

Authors: Aukje K Mantel-Teeuwisse; Olaf H Klungel; Tom Schalekamp; W M Monique Verschuren; Arijan J Porsius; Anthonius de Boer
Journal: Br J Clin Pharmacol Date: 2005-07 Impact factor: 4.335

Review 4. Clinical practice guideline for cardiovascular risk management in the Netherlands.

Authors: Y M Smulders; J S Burgers; T Scheltens; B A van Hout; T Wiersma; M L Simoons
Journal: Neth J Med Date: 2008-04 Impact factor: 1.422

Review 5. The Nordic countries as a cohort for pharmacoepidemiological research.

Authors: Kari Furu; Björn Wettermark; Morten Andersen; Jaana E Martikainen; Anna Birna Almarsdottir; Henrik Toft Sørensen
Journal: Basic Clin Pharmacol Toxicol Date: 2009-12-04 Impact factor: 4.080

6. Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.

Authors: Marjolein Geleedst-De Vooght; Anke-Hilse Maitland-van der Zee; Tom Schalekamp; Aukje Mantel-Teeuwisse; Paul Jansen
Journal: Drugs Aging Date: 2010-07-01 Impact factor: 3.923

7. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors:
Journal: Lancet Date: 1994-11-19 Impact factor: 79.321

Review 8. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials.

Authors: J J Brugts; T Yetgin; S E Hoeks; A M Gotto; J Shepherd; R G J Westendorp; A J M de Craen; R H Knopp; H Nakamura; P Ridker; R van Domburg; J W Deckers
Journal: BMJ Date: 2009-06-30

9. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors: C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal: Lancet Date: 2010-11-08 Impact factor: 79.321

10. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors:
Journal: Lancet Date: 2002-07-06 Impact factor: 79.321

1 in total

1. Value of genetic testing in the prevention of coronary heart disease events.

Authors: Yrjänä Hynninen; Miika Linna; Eeva Vilkkumaa
Journal: PLoS One Date: 2019-01-15 Impact factor: 3.240

1 in total